Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.
about
Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues.Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling.Nitroxide stable radicals protect beating cardiomyocytes against oxidative damageReperfusion injury.Role of cytochrome P-450 in reperfusion injury of the rabbit lungOxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts.Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers.Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating NOS and generating mitochondrial ROS.Acute iron poisoning. Rescue with macromolecular chelatorsEndothelial superoxide production in the isolated rat heart during early reperfusion after ischemia. A histochemical studyLipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury.Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial InjuryDetermination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kineticsStunning: a radical re-view.Protective effects of vitamin D3 on fimbrial cells exposed to catalytic iron damageCardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarctionSerum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysisIntralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques.Cardiac reperfusion damage prevented by a nitroxide free radical.To prevent, protect and save the ischemic heart: antioxidants revisited.Effect of intravenous administration of antioxidants alone and in combination on myocardial reperfusion injury in an experimental pig model.Intravenous rutin in rat exacerbates isoprenaline-induced cardiotoxicity likely due to intracellular oxidative stress.Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway.Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factorReappraisal of the e.p.r. signals in (post)-ischaemic cardiac tissue.Spin trapping evidence for radical generation by isolated hearts and cultured heart cells.Measurement and characterization of free radical generation in reoxygenated human endothelial cells.Timing of treatment with oxygen radical scavengers and its influence on reperfusion injury.Inhibitors of the activity of poly (ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts.Reactive oxygen species generated during myocardial ischemia enable energetic recovery during reperfusion.Cardioprotective and antioxidant effects of apomorphine.Elevated MnSOD is not required for exercise-induced cardioprotection against myocardial stunning.Continuous intravenous infusion of deferoxamine reduces mortality by paraquat in vitamin E-deficient rats.Oxidative stress in ischemia and reperfusion: current concepts, novel ideas and future perspectives.Dysregulation of hepatic iron with aging: implications for heat stress-induced oxidative liver injury.Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration.Influence of postischemic administration of oxyradical antagonists on ischemic injury to rabbit skeletal muscle.Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice.Dietary haem iron and coronary heart disease in women.
P2860
Q33579059-07F645F1-CC5B-4CD0-B667-0FAD00817923Q33861991-CC770B89-79C1-4DCF-A96F-F73AD19F07ABQ34186953-2D50EFF2-C184-4E1D-9574-D08843CA76FDQ34206477-F3C23A59-EA79-4824-BC67-438871EBC482Q34262890-9A3F9FD4-D3FC-4DFD-A375-E4D2CD223462Q34264913-47E15F71-B1CC-4A44-998A-E125019CC0C6Q34326858-AB5D9AE0-838D-4530-BA8C-08D6D18C4966Q34450007-875F058E-91D4-4072-9601-E844F4113A5AQ35816512-011DB9C7-B1BA-4C3D-AC39-BA4C7A7DA432Q35831156-A9A79B87-BA83-41A7-A1AE-46816A0A434AQ36068269-3DE4D3A4-2443-4D26-9D2F-4D5BECC597C9Q36405689-B1647B51-7808-4692-ABE5-A99E36939518Q36797154-0AC07D78-FE02-4BD4-8BA0-86CD417D335CQ36846547-3D081682-A37A-4B7E-A815-F87B06F96EEFQ37017956-90DF12FF-B4E1-4989-8DED-6F6A0BDC03EFQ37088307-6678184F-2FB7-4A0D-8381-086D682478F9Q37150884-7EC713C6-4819-43C3-A1AE-C52CEF64A56FQ37160450-4A1407E2-A1CA-48CB-A1A9-CC30238F8443Q37311902-B7E8EFBE-7B85-49C5-945B-48F9C4AED11AQ37520093-CAD0C5EA-D736-49F6-B5C3-E1A94A41184FQ37522464-5201BE53-7D7C-4D51-A20F-789AA0F18F4CQ37672725-C209B59D-57A4-4D7D-95C3-A49650F324DBQ38778332-D0AC6F08-7AF4-450F-8776-40173619A980Q39083407-AA8CA7DB-C1EF-4E83-B1EA-10BADE43E142Q40336954-5B0E48E3-D208-41F6-BCF8-EE1F28DB9BA4Q41209999-193CB9AD-377F-4355-91BC-F1D4C8303CEBQ41272669-FC5C4737-58B6-41B9-B643-E65BAF2AA498Q41482413-FFD4A45C-91DA-4FD9-9BA5-E09627D8F359Q42980191-A8F1EC05-6D38-475B-A559-C41AF29B40B4Q43185132-7C608FBB-DB4E-4F38-9B37-E31D5A8C3E3CQ44138457-4172DE8F-B866-4666-9F9F-BA86765C7AFFQ44544786-FA8AFBF7-C60C-4E24-8190-852770A9F3EDQ44805460-AC3520B3-897A-49EE-AB13-F558E286550AQ44901125-EA09D778-9673-4CCA-B66B-F364781B1BC2Q46283292-4AA010CB-A53F-4A42-AB46-6675394DB10CQ46755489-A1B47DAE-D4EE-4AA0-B4BE-F70BF3C64901Q48291438-D0BD9CC4-0137-4444-9CDB-B6F3E5CADAEBQ50753261-0AF1CF48-74B3-4813-91BB-6470F09BD134Q53649105-462C8F72-2075-4A45-ADB6-CD6A832B9201Q54678929-91B8FEE0-73FA-460F-B82E-931A0D357B0E
P2860
Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Improvement of postischemic my ...... genesis of reperfusion injury.
@en
type
label
Improvement of postischemic my ...... genesis of reperfusion injury.
@en
prefLabel
Improvement of postischemic my ...... genesis of reperfusion injury.
@en
P2093
P356
P1433
P1476
Improvement of postischemic my ...... genesis of reperfusion injury.
@en
P2093
Ambrosio G
Flaherty JT
Jacobus WE
Weisfeldt ML
P304
P356
10.1161/01.CIR.76.4.906
P407
P577
1987-10-01T00:00:00Z